Optibrium
Optibrium provides innovative in silico platforms and AI solutions that accelerate drug discovery programs. Their core offering, StarDrop™, is a comprehensive suite for molecular design, optimization, and data analysis. The company also offers Cerella™ for AI-guided discovery, Semeta™ for metabolism insights, and BioPharmics™ for 3D molecular design. Optibrium's solutions aim to increase speed, efficiency, and productivity in the drug discovery process, by leveraging cutting-edge science, rigorous research, and intuitive software. They have demonstrated capabilities in handling large datasets, such as processing 700,000 compounds for Takeda Pharmaceuticals and achieving a 76% reduction in assays for Genentech.
Optibrium
Optibrium provides innovative in silico platforms and AI solutions that accelerate drug discovery programs. Their core offering, StarDrop™, is a comprehensive suite for molecular design, optimization, and data analysis. The company also offers Cerella™ for AI-guided discovery, Semeta™ for metabolism insights, and BioPharmics™ for 3D molecular design. Optibrium's solutions aim to increase speed, efficiency, and productivity in the drug discovery process, by leveraging cutting-edge science, rigorous research, and intuitive software. They have demonstrated capabilities in handling large datasets, such as processing 700,000 compounds for Takeda Pharmaceuticals and achieving a 76% reduction in assays for Genentech.